Cachexia in cancer patients

Michael J. Tisdale

Research output: Contribution to journalArticle

Abstract

Cachexia — the massive (up to 80%) loss of both adipose tissue and skeletal muscle mass — is a significant factor in the poor performance status and high mortality rate of cancer patients. Although this metabolic defect has been known since cancer was first studied, it is only recently that major advances have been made in the identification of catabolic factors that act to destroy host tissues during the cachectic process. Although anorexia is frequently present, depression of food intake alone seems not to be responsible for the wasting of body tissues, as nutritional supplementation or pharmacological manipulation of appetite is unable to reverse the catabolic process — particularly with respect to skeletal muscle. However, recent clinical studies in cancer patients have shown that nutritional supplementation can be effective when combined with agents that attenuate the action of tumour factors and modifiers of the central effects on appetite might also show promise.
Original languageEnglish
Pages (from-to)862-871
Number of pages10
JournalNature Reviews: Cancer
Volume2
Issue number11
DOIs
Publication statusPublished - Nov 2002

Fingerprint

Cachexia
Appetite
Neoplasms
Skeletal Muscle
Anorexia
Adipose Tissue
Eating
Pharmacology
Mortality

Keywords

  • cachexia
  • adipose tissue
  • skeletal muscle mass
  • mortality rate
  • cancer patients
  • cancer
  • catabolic factors
  • catabolic process
  • skeletal muscle
  • nutritional supplementation

Cite this

Tisdale, Michael J. / Cachexia in cancer patients. In: Nature Reviews: Cancer. 2002 ; Vol. 2, No. 11. pp. 862-871.
@article{e3f5ead55e924d4ba3ea0e59b6b6bc7f,
title = "Cachexia in cancer patients",
abstract = "Cachexia — the massive (up to 80{\%}) loss of both adipose tissue and skeletal muscle mass — is a significant factor in the poor performance status and high mortality rate of cancer patients. Although this metabolic defect has been known since cancer was first studied, it is only recently that major advances have been made in the identification of catabolic factors that act to destroy host tissues during the cachectic process. Although anorexia is frequently present, depression of food intake alone seems not to be responsible for the wasting of body tissues, as nutritional supplementation or pharmacological manipulation of appetite is unable to reverse the catabolic process — particularly with respect to skeletal muscle. However, recent clinical studies in cancer patients have shown that nutritional supplementation can be effective when combined with agents that attenuate the action of tumour factors and modifiers of the central effects on appetite might also show promise.",
keywords = "cachexia, adipose tissue, skeletal muscle mass, mortality rate, cancer patients, cancer, catabolic factors, catabolic process, skeletal muscle, nutritional supplementation",
author = "Tisdale, {Michael J.}",
year = "2002",
month = "11",
doi = "10.1038/nrc927",
language = "English",
volume = "2",
pages = "862--871",
journal = "Nature Reviews: Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "11",

}

Tisdale, MJ 2002, 'Cachexia in cancer patients', Nature Reviews: Cancer, vol. 2, no. 11, pp. 862-871. https://doi.org/10.1038/nrc927

Cachexia in cancer patients. / Tisdale, Michael J.

In: Nature Reviews: Cancer, Vol. 2, No. 11, 11.2002, p. 862-871.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cachexia in cancer patients

AU - Tisdale, Michael J.

PY - 2002/11

Y1 - 2002/11

N2 - Cachexia — the massive (up to 80%) loss of both adipose tissue and skeletal muscle mass — is a significant factor in the poor performance status and high mortality rate of cancer patients. Although this metabolic defect has been known since cancer was first studied, it is only recently that major advances have been made in the identification of catabolic factors that act to destroy host tissues during the cachectic process. Although anorexia is frequently present, depression of food intake alone seems not to be responsible for the wasting of body tissues, as nutritional supplementation or pharmacological manipulation of appetite is unable to reverse the catabolic process — particularly with respect to skeletal muscle. However, recent clinical studies in cancer patients have shown that nutritional supplementation can be effective when combined with agents that attenuate the action of tumour factors and modifiers of the central effects on appetite might also show promise.

AB - Cachexia — the massive (up to 80%) loss of both adipose tissue and skeletal muscle mass — is a significant factor in the poor performance status and high mortality rate of cancer patients. Although this metabolic defect has been known since cancer was first studied, it is only recently that major advances have been made in the identification of catabolic factors that act to destroy host tissues during the cachectic process. Although anorexia is frequently present, depression of food intake alone seems not to be responsible for the wasting of body tissues, as nutritional supplementation or pharmacological manipulation of appetite is unable to reverse the catabolic process — particularly with respect to skeletal muscle. However, recent clinical studies in cancer patients have shown that nutritional supplementation can be effective when combined with agents that attenuate the action of tumour factors and modifiers of the central effects on appetite might also show promise.

KW - cachexia

KW - adipose tissue

KW - skeletal muscle mass

KW - mortality rate

KW - cancer patients

KW - cancer

KW - catabolic factors

KW - catabolic process

KW - skeletal muscle

KW - nutritional supplementation

UR - http://www.nature.com/nrc/journal/v2/n11/full/nrc927.html

U2 - 10.1038/nrc927

DO - 10.1038/nrc927

M3 - Article

VL - 2

SP - 862

EP - 871

JO - Nature Reviews: Cancer

JF - Nature Reviews: Cancer

SN - 1474-175X

IS - 11

ER -